CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 53 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $3,000 | -70.0% | 250 | -75.0% | 0.00% | -75.0% |
| Q1 2018 | $10,000 | -23.1% | 1,000 | +25.0% | 0.00% | -33.3% |
| Q3 2017 | $13,000 | +30.0% | 800 | 0.0% | 0.01% | +20.0% |
| Q2 2017 | $10,000 | -41.2% | 800 | 0.0% | 0.01% | -44.4% |
| Q1 2017 | $17,000 | +54.5% | 800 | 0.0% | 0.01% | +80.0% |
| Q4 2016 | $11,000 | -15.4% | 800 | 0.0% | 0.01% | -44.4% |
| Q3 2016 | $13,000 | +116.7% | 800 | +100.0% | 0.01% | +125.0% |
| Q2 2016 | $6,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $8,746,000 | 1.82% |
| Telemetry Investments, L.L.C. | 263,975 | $705,000 | 0.97% |
| CHI Advisors LLC | 719,132 | $1,920,000 | 0.45% |
| BVF INC/IL | 3,678,626 | $9,822,000 | 0.37% |
| EcoR1 Capital, LLC | 3,579,377 | $9,557,000 | 0.36% |
| Orbimed Advisors | 8,053,298 | $21,502,000 | 0.22% |
| Stonepine Capital Management, LLC | 46,886 | $125,000 | 0.06% |
| Ikarian Capital, LLC | 100,000 | $267,000 | 0.02% |
| ALGERT GLOBAL LLC | 19,737 | $53,000 | 0.02% |
| Windsor Creek Advisors, LLC | 14,786 | $39,000 | 0.01% |